SRP-9003
SRP-9003-301
Phase 3 mab active
Quick answer
SRP-9003 for Limb-girdle Muscular Dystrophy is a Phase 3 program (mab) at Sarepta Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Sarepta Therapeutics
- Indication
- Limb-girdle Muscular Dystrophy
- Phase
- Phase 3
- Modality
- mab
- Status
- active